| pubmed-article:12742337 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12742337 | lifeskim:mentions | umls-concept:C0205282 | lld:lifeskim |
| pubmed-article:12742337 | lifeskim:mentions | umls-concept:C0149614 | lld:lifeskim |
| pubmed-article:12742337 | lifeskim:mentions | umls-concept:C0205183 | lld:lifeskim |
| pubmed-article:12742337 | lifeskim:mentions | umls-concept:C0085264 | lld:lifeskim |
| pubmed-article:12742337 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12742337 | pubmed:dateCreated | 2003-5-13 | lld:pubmed |
| pubmed-article:12742337 | pubmed:abstractText | Ultrasound scanning, serum CA125 and menopausal status have previously been combined in a risk of malignancy index for the differential diagnosis of adnexal masses. Although this approach has greater accuracy than either individual tests or clinical assessment, it has a significant false positive and false negative rate. Efforts have been directed at refining differential diagnosis and this study assessed the role of radioimmunoscintigraphy using the stripped mucin 3 (SM3) antibody that has a 17-fold greater uptake in malignant than benign ovarian tumours in vitro. | lld:pubmed |
| pubmed-article:12742337 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12742337 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12742337 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12742337 | pubmed:month | May | lld:pubmed |
| pubmed-article:12742337 | pubmed:issn | 1470-0328 | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:AliNN | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:BrittonK EKE | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:GranowskaMM | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:JacobiWW | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:JanHH | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:CarrollM JMJ | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:Van TrappenPP | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:CanizalesAA | lld:pubmed |
| pubmed-article:12742337 | pubmed:author | pubmed-author:NasreenFF | lld:pubmed |
| pubmed-article:12742337 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12742337 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:12742337 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12742337 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12742337 | pubmed:pagination | 508-14 | lld:pubmed |
| pubmed-article:12742337 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:meshHeading | pubmed-meshheading:12742337... | lld:pubmed |
| pubmed-article:12742337 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12742337 | pubmed:articleTitle | Radioimmunoscintigraphy with Tc-99m-labelled SM3 in differentiating malignant from benign adnexal masses. | lld:pubmed |
| pubmed-article:12742337 | pubmed:affiliation | Department of Nuclear Medicine, Bart's and the London, Queen Mary School of Medicine and Dentistry, London University, UK. | lld:pubmed |
| pubmed-article:12742337 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12742337 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
